-
Study aim
-
A clinical trial to compare the effectiveness of remote ischemic preconditioning and primary coronary percutaneous intervention on cardiovascular outcomes in patients with acute myocardial infarction.
-
Design
-
In this pragmatic double-blind, controlled clinical trial, sixty patients with acute myocardial infarction were assigned into parallel groups using the table of random numbers in a community-based setting.
-
Settings and conduct
-
Patients with acute myocardial infarction at the Department of Cardiology, Ghaem Hospital, Mashhad, Iran, were chosen. In this double-blind study, the clinical care and data collector were blind to group assignment and the type of treatment.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age higher than 20 years; an elapse of 12 hours form the primary diagnosis.
Exclusion criteria: Thrombolysis in myocardial infarction (TIMI) score of 2-3; Rentrop grade of >1; need for coronary artery bypass graft; cardiogenic shock.
-
Intervention groups
-
The intervention group will receive remote ischemic preconditioning. In this method, a blood pressure cuff is fastened on one of the patient's organs before surgery, and the cuff is intermittently blown and drained to restrict blood flow and reestablish it. The control group will receive primary coronary percutaneous intervention. In this method, a tube with a balloon at the end, called the catheter, is moved into the coronary artery toward the blockage. After the dilatation of the vessel, the balloon is evacuated, and the catheter is pulled out.
-
Main outcome variables
-
Evaluation and comparison of major adverse cardiovascular events (mortality, second myocardial infarction, etc), the reduction of ST-segment as an indicator of microvascular reperfusion, thrombolysis in myocardial infarction flow, and cardiac enzymes before and 24 hours after the intervention in the intervention and control groups.